查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1713709

2025年兽医循环系统全球市场报告

Veterinary Cardiology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年兽医循环系统市场规模将强劲成长。到 2029 年，这一数字将成长至 43.5 亿美元，年复合成长率（CAGR）为 8.8%。预测期内的成长归因于对兽医循环系统研究的投资增加、远距咨询的远端医疗服务的扩展、宠物拥有率的增长、消费者对专业兽医护理的需求增加以及高级兽医循环系统培训计画的增加。预测期内的主要趋势包括云端安全解决方案、整合协作平台、对资料隐私和合规性的更多关注、加速向多重云端环境的迁移以及高度扩充性和灵活的云端基础设施解决方案的开发。

宠物和牲畜心臟病发病率的不断上升预计将在未来几年推动兽医循环系统市场的成长。动物的这些心臟疾病会影响心臟的结构和功能，导致血液循环不良、心臟效率降低和潜在的健康併发症。导致宠物和牲畜心臟病增加的因素包括寿命延长、肥胖、营养不良、遗传因素和缺乏常规兽医护理。此外，环境压力和生活条件的变化也可能增加这些动物心血管疾病的发生率。兽医循环系统在宠物和牲畜心臟病的诊断、治疗和管理中发挥着至关重要的作用，透过专门的护理、先进的影像技术和创新程序（包括微创手术）来改善心臟健康和整体生活品质。例如，根据美国兽医协会2024年3月的报告，黏液瘤性二尖瓣变性（MMVD）是北美最常见的犬类心臟病，占所有犬类心臟病的75%。据报道，13 岁的小型犬中高达 85% 会出现黏液瘤性二尖瓣疾病的迹象，但这并不一定具有临床意义。二尖瓣瓣膜闭锁不全导致的狗心臟病死亡率估计为 40% 至 70%。因此，宠物和牲畜心臟病盛行率的不断上升将推动兽医循环系统市场的扩张。

兽医循环系统领域的主要企业正专注于经导管端到端二尖瓣修復 (TEER) 等技术进步，以增强心臟疾病的治疗、改善手术效果并提供微创选择，以实现更好的康復和生活品质。 TEER 是一种微创手术，透过钳子解决二尖瓣漏气问题，以改善瓣膜功能并减轻心臟的压力。例如，2023 年 2 月，英国兽医转诊中心 Willows Animal Hospital 为患有黏液瘤性二尖瓣疾病 (MMVD) 的狗推出了一种新的心臟治疗方法，这是狗中最常见的心臟疾病。这种治疗方法被认为是人类传统手术的可行替代方案，在狗身上的早期临床结果也令人鼓舞。进行全身麻醉后，在胸壁上做一个小切口，使用连续的X射线和经食道超音波引导针头到达心尖，从而将 V 型钳精确放置在二尖瓣上以减少洩漏。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球兽医循环系统PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球兽医循环系统市场：成长率分析
  • 全球兽医循环系统学市场表现：规模与成长，2019-2024
  • 全球兽医循环系统市场预测：规模与成长，2024-2029 年，2034 年
  • 全球兽医循环系统总目标市场（TAM）

第六章市场区隔

  • 全球兽医循环系统市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 製药
  • 诊断
  • 全球兽医循环系统市场（按适应症、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 郁血性心臟衰竭衰竭
  • 心肌疾病
  • 心律不整
  • 其他适应症
  • 全球兽医循环系统市场（按动物类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 伴同性动物
  • 生产动物
  • 全球兽医循环系统市场（按最终用户、业绩和预测），2019-2024 年、2024-2029 年、2034 年
  • 兽医诊所
  • 诊所
  • 其他最终用户
  • 全球兽医循环系统市场细分（依药物类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 抗高血压药
  • 利尿剂
  • 抗心律不整药物
  • β受体阻断剂
  • 血管紧张素转换酶抑制剂
  • 钙离子通道阻断剂
  • 正性肌力药物
  • 有益心臟健康的膳食补充剂
  • 全球兽医循环系统学市场，诊断细分，按类型、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 心电图（ECG）
  • 心臟超音波图设备
  • 心电图监测
  • 血压计
  • 心臟生物标记检测
  • 胸部X光检查
  • 超音波设备
  • 心臟监测远端医疗解决方案

第七章 区域和国家分析

  • 全球兽医循环系统市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球兽医循环系统市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 兽医循环系统市场：竞争格局
  • 兽医循环系统市场：公司简介
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Royal Canin
  • IDEXX Laboratories Inc.
  • Ceva Sante Animale SA
  • Fujifilm Healthcare Solutions
  • Dechra Pharmaceuticals PLC
  • Vetoquinol SA
  • ESAOTE SpA
  • SonoScape Medical Corp.
  • Jurox Pty Limited
  • Eickemeyer Veterinary Equipment GmbH
  • VetriScience Laboratories Inc.
  • Bionet America Inc.
  • Scil Animal Care Company
  • Woodley Equipment Company Ltd.
  • Universal Imaging Corporation

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年兽医循环系统市场：提供新机会的国家
  • 2029年兽医循环系统市场：细分市场带来新机会
  • 2029年兽医循环系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r33611

Veterinary cardiology is a specialized field of veterinary medicine dedicated to diagnosing and managing heart diseases in animals. This branch ranges from routine examinations to advanced treatments, aiming to enhance pets' quality of life by providing targeted diagnosis and treatment for heart conditions, which leads to better health outcomes and longer lifespans.

The primary product types in veterinary cardiology are pharmaceuticals and diagnostics. Pharmaceuticals refer to the medications used to treat heart conditions in animals, such as managing heart failure, arrhythmias, and other cardiovascular issues. Indications for these medications include congestive heart failure, myocardial disease, arrhythmias, and other heart conditions affecting companion animals and production animals. The end users of these products include veterinary hospitals, clinics, and other related facilities.

The veterinary cardiology market research report is one of a series of new reports from the business research company that provides veterinary cardiology market statistics, including veterinary cardiology industry global market size, regional shares, competitors with an veterinary cardiology market share, detailed veterinary cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary cardiology industry. This veterinary cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary cardiology market size has grown strongly in recent years. It will grow from $2.84 billion in 2024 to $3.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increasing pet ownership, growing awareness of pet health, rising prevalence of cardiac disorders in animals, expansion of veterinary specialty clinics, and the increasing availability and affordability of pet insurance.

The veterinary cardiology market size is expected to see strong growth in the next few years. It will grow to $4.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing investment in veterinary cardiology research, expansion of telemedicine services for remote consultations, growth in pet adoption rates, rising consumer demand for specialized veterinary care, and the increasing availability of advanced veterinary cardiology training programs. Major trends in the forecast period include cloud security solutions, integrated collaboration platforms, enhanced focus on data privacy and compliance, accelerated migration to multi-cloud environments, and the development of more scalable and flexible cloud infrastructure solutions.

The increasing incidence of heart diseases in both pets and livestock is anticipated to drive growth in the veterinary cardiology market in the future. These heart conditions in animals impact the heart's structure and functionality, resulting in compromised blood circulation, diminished cardiac efficiency, and possible health complications. Contributing factors to the rise in heart diseases among pets and livestock include longer lifespans, obesity, poor nutrition, genetic factors, and insufficient routine veterinary care. Moreover, environmental stressors and changes in living conditions may also heighten the occurrence of cardiovascular diseases in these animals. Veterinary cardiology plays a crucial role in diagnosing, treating, and managing heart diseases in pets and livestock, utilizing specialized care, advanced imaging techniques, and innovative procedures such as minimally invasive surgeries to enhance heart health and overall quality of life. For example, as reported by the American Veterinary Medical Association in March 2024, Myxomatous mitral valve degeneration (MMVD) is the most common heart disease affecting dogs in North America, accounting for 75% of all canine cardiac conditions. It is noted that 85% of small dogs aged 13 years exhibit signs of a myxomatous mitral valve lesion, although this does not always indicate clinical significance. In MMVD cases, the estimated rate of cardiac-related fatalities in dogs ranges from 40% to 70%. Consequently, the growing prevalence of heart diseases in pets and livestock is set to propel the veterinary cardiology market's expansion.

Leading companies in the veterinary cardiology sector are focusing on technological advancements such as transcatheter edge-to-edge mitral valve repair (TEER) to enhance the treatment of heart diseases, improve surgical outcomes, and provide minimally invasive options for better recovery and quality of life. TEER is a less invasive procedure that addresses mitral valve leakage by using a clamp to improve valve function and reduce heart strain. For instance, in February 2023, Willows Veterinary Centre, a veterinary referral center based in the UK, introduced a novel heart treatment for dogs with myxomatous mitral valve disease (MMVD), the most common heart condition in dogs. This procedure, which is considered a viable alternative to traditional surgery in humans, has shown promising early clinical results in dogs. It involves general anesthesia and a minor chest wall incision, with a needle guided to the heart's apex using continuous X-rays and transesophageal ultrasound to precisely place a V-clamp across the mitral valve to reduce leakage.

In October 2023, EQT AB, a Swedish investment organization, acquired VetPartners for $940 million. This acquisition aligns with EQT's strategy to expand its investment in the animal health sector, aiming to enhance veterinary services and meet the growing demand for animal healthcare. VetPartners, based in the UK, is a veterinary group that offers comprehensive cardiology care and services for animals.

Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Sante Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet

North America was the largest region in the veterinary cardiology market in 2024. The regions covered in the veterinary cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary cardiology market consists of revenues earned by entities by providing services such as educational services, emergency care, telemedicine services, follow-up care, and consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. veterinary cardiology market also includes sales of monitoring devices, treatment products, supportive products, and surgical products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Cardiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary cardiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary cardiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary cardiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Pharmaceuticals; Diagnostics
  • 2) By Indication: Congestive Heart Failure; Myocardial (Heart Muscle) Disease; Arrhythmias; Other Indications
  • 3) By Animal Type: Companion Animals; Production Animals
  • 4) By End-User: Veterinary Hospitals; Clinics; Other End Users
  • Subsegments:
  • 1) By Pharmaceuticals: Antihypertensives; Diuretics; Antiarrhythmic Drugs; Beta Blockers; ACE Inhibitors; Calcium Channel Blockers; Positive Inotropes; Nutraceuticals For Cardiac Health
  • 2) By Diagnostics: Electrocardiograms (ECG); Echocardiography Devices; Holter Monitors; Blood Pressure Monitors; Cardiac Biomarker Tests; Thoracic Radiography; Ultrasound Devices; Telemedicine Solutions for Cardiac Monitoring
  • Companies Mentioned: Merck & Co. Inc.; Medtronic plc; Siemens Healthineers AG; Zoetis Inc.; Boehringer Ingelheim Animal Health
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Cardiology Market Characteristics

3. Veterinary Cardiology Market Trends And Strategies

4. Veterinary Cardiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Veterinary Cardiology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Veterinary Cardiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Veterinary Cardiology Market Growth Rate Analysis
  • 5.4. Global Veterinary Cardiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Veterinary Cardiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Veterinary Cardiology Total Addressable Market (TAM)

6. Veterinary Cardiology Market Segmentation

  • 6.1. Global Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceuticals
  • Diagnostics
  • 6.2. Global Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Congestive Heart Failure
  • Myocardial (Heart Muscle) Disease
  • Arrhythmias
  • Other Indications
  • 6.3. Global Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Companion Animals
  • Production Animals
  • 6.4. Global Veterinary Cardiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Veterinary Hospitals
  • Clinics
  • Other End Users
  • 6.5. Global Veterinary Cardiology Market, Sub-Segmentation Of Pharmaceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antihypertensives
  • Diuretics
  • Antiarrhythmic Drugs
  • Beta Blockers
  • ACE Inhibitors
  • Calcium Channel Blockers
  • Positive Inotropes
  • Nutraceuticals For Cardiac Health
  • 6.6. Global Veterinary Cardiology Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electrocardiograms (ECG)
  • Echocardiography Devices
  • Holter Monitors
  • Blood Pressure Monitors
  • Cardiac Biomarker Tests
  • Thoracic Radiography
  • Ultrasound Devices
  • Telemedicine Solutions for Cardiac Monitoring

7. Veterinary Cardiology Market Regional And Country Analysis

  • 7.1. Global Veterinary Cardiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Veterinary Cardiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Cardiology Market

  • 8.1. Asia-Pacific Veterinary Cardiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Cardiology Market

  • 9.1. China Veterinary Cardiology Market Overview
  • 9.2. China Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Cardiology Market

  • 10.1. India Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Cardiology Market

  • 11.1. Japan Veterinary Cardiology Market Overview
  • 11.2. Japan Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Cardiology Market

  • 12.1. Australia Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Cardiology Market

  • 13.1. Indonesia Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Cardiology Market

  • 14.1. South Korea Veterinary Cardiology Market Overview
  • 14.2. South Korea Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Cardiology Market

  • 15.1. Western Europe Veterinary Cardiology Market Overview
  • 15.2. Western Europe Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Cardiology Market

  • 16.1. UK Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Cardiology Market

  • 17.1. Germany Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Cardiology Market

  • 18.1. France Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Cardiology Market

  • 19.1. Italy Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Cardiology Market

  • 20.1. Spain Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Cardiology Market

  • 21.1. Eastern Europe Veterinary Cardiology Market Overview
  • 21.2. Eastern Europe Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Cardiology Market

  • 22.1. Russia Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Cardiology Market

  • 23.1. North America Veterinary Cardiology Market Overview
  • 23.2. North America Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Cardiology Market

  • 24.1. USA Veterinary Cardiology Market Overview
  • 24.2. USA Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Cardiology Market

  • 25.1. Canada Veterinary Cardiology Market Overview
  • 25.2. Canada Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Cardiology Market

  • 26.1. South America Veterinary Cardiology Market Overview
  • 26.2. South America Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Cardiology Market

  • 27.1. Brazil Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Cardiology Market

  • 28.1. Middle East Veterinary Cardiology Market Overview
  • 28.2. Middle East Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Cardiology Market

  • 29.1. Africa Veterinary Cardiology Market Overview
  • 29.2. Africa Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Cardiology Market Competitive Landscape And Company Profiles

  • 30.1. Veterinary Cardiology Market Competitive Landscape
  • 30.2. Veterinary Cardiology Market Company Profiles
    • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Cardiology Market Other Major And Innovative Companies

  • 31.1. Royal Canin
  • 31.2. IDEXX Laboratories Inc.
  • 31.3. Ceva Sante Animale S.A.
  • 31.4. Fujifilm Healthcare Solutions
  • 31.5. Dechra Pharmaceuticals PLC
  • 31.6. Vetoquinol S.A.
  • 31.7. ESAOTE S.p.A.
  • 31.8. SonoScape Medical Corp.
  • 31.9. Jurox Pty Limited
  • 31.10. Eickemeyer Veterinary Equipment GmbH
  • 31.11. VetriScience Laboratories Inc.
  • 31.12. Bionet America Inc.
  • 31.13. Scil Animal Care Company
  • 31.14. Woodley Equipment Company Ltd.
  • 31.15. Universal Imaging Corporation

32. Global Veterinary Cardiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Cardiology Market

34. Recent Developments In The Veterinary Cardiology Market

35. Veterinary Cardiology Market High Potential Countries, Segments and Strategies

  • 35.1 Veterinary Cardiology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Veterinary Cardiology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Veterinary Cardiology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33611_Veterinary_Cardiology_GMR_2025